Natural Products and some Semi-synthetic Analogues as Potential TRPV1 Ligands for Attenuating Neuropathic Pain

被引:21
作者
Naik, Gaurav Gopal [1 ]
Uniyal, Ankit [1 ]
Chouhan, Deepak [1 ]
Tiwari, Vinod [1 ]
Sahu, Alakh N. [1 ]
机构
[1] Indian Inst Technol BHU Varanasi, Dept Pharmaceut Engn & Technol, Varanasi, Uttar Pradesh, India
关键词
TRPV1; channels; neuropathic pain; natural products; semi-synthetic analogues; agonists; antagonists; ROOT GANGLION NEURONS; ION-CHANNEL; VANILLOID; RAT MODEL; ALLYL ISOTHIOCYANATE; CAPSAICIN RECEPTOR; PUNGENT COMPOUNDS; PANAX-GINSENG; BLACK PEPPER; ACTIVATION;
D O I
10.2174/1389201022666210719155931
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Natural products and leads inspired by them have acted as a probe for successful drug discovery for many decades. Pain is an obnoxious sensory and emotional experience associated with potential tissue damage. It affects the quality of life of patients to a greater extent. Despite the availability of several agents targeting TRP receptors, none of them can proficiently alleviate neuropathic pain. TRPV1 is a prospective target for treating neuropathic pain as it is recognized to modulate the pain circuitry at the periphery and the central level. In this review, we have discussed several natural molecules, such as Capsaicinoids, Capsinoids, Piperine, Eugenol, Scutigeral, Ginsenosides, Cinnamaldehyde, Camphor, Shogaol, Gingerols, Zingerone, Allicin, Evodiamine, Allylisothiocyanate, Cannabidiol, Ricinoleic acid, Isovelleral, Capsazepine, Thapsigargin, Pellitorine, Yohimbine, Curcumin and some semi-synthetic analogues that activate TRPV1 channels and consequently, can be further harnessed for the treatment of neuropathic pain.
引用
收藏
页码:766 / 786
页数:21
相关论文
共 151 条
  • [51] Iadarola Michael J, 2013, Open Pain J, V6, P95
  • [52] TRPV1-Targeted Drugs in Development for Human Pain Conditions
    Iftinca, Mircea
    Defaye, Manon
    Altier, Christophe
    [J]. DRUGS, 2021, 81 (01) : 7 - 27
  • [53] Evodiamine suppresses capsaicin-induced thermal hyperalgesia through activation and subsequent desensitization of the transient receptor potential V1 channels
    Iwaoka, Emiko
    Wang, Shenglan
    Matsuyoshi, Nobuyuki
    Kogure, Yoko
    Aoki, Shunji
    Yamamoto, Satoshi
    Noguchi, Koichi
    Dai, Yi
    [J]. JOURNAL OF NATURAL MEDICINES, 2016, 70 (01) : 1 - 7
  • [54] Monoacylglycerols activate capsaicin receptor, TRPV1
    Iwasaki, Yusaku
    Saito, Orine
    Tanabe, Manabu
    Inayoshi, Kimiko
    Kobata, Kenji
    Uno, Shuichi
    Morita, Akihito
    Watanabe, Tatsuo
    [J]. LIPIDS, 2008, 43 (06) : 471 - 483
  • [55] A nonpungent component-of steamed ginger-[10]-shogaol-increases adrenaline secretion via the activation of TRPV1
    Iwasaki, Yusaku
    Morita, Akhito
    Iwasawa, Takahito
    Kobata, Kenji
    Sekiwa, Youko
    Morimitsu, Yasujiro
    Kubota, Kikue
    Watanabe, Tatsuo
    [J]. NUTRITIONAL NEUROSCIENCE, 2006, 9 (3-4) : 169 - 178
  • [56] Thapsigargin-From Traditional Medicine to Anticancer Drug
    Jaskulska, Agata
    Janecka, Anna Ewa
    Gach-Janczak, Katarzyna
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (01) : 1 - 12
  • [57] TRPM Channels in Human Diseases
    Jimenez, Ivanka
    Prado, Yolanda
    Marchant, Felipe
    Otero, Carolina
    Eltit, Felipe
    Cabello-Verrugio, Claudio
    Cerda, Oscar
    Simon, Felipe
    [J]. CELLS, 2020, 9 (12)
  • [58] Jin SX, 2003, J NEUROSCI, V23, P4017
  • [59] Jung SY, 2001, MOL CELLS, V12, P342
  • [60] Effects of the vanilloid agonist olvanil and antagonist capsazepine on rat behaviors
    Kasckow, JW
    Mulchahey, JJ
    Geracioti, TD
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2004, 28 (02) : 291 - 295